(Q43889328)

reason for preferred rank

27 November 2017

title

Measurement of CSF dynorphin a 1–8 immunoreactivity in anorexia nervosa and normal-weight bulimia (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

25 October 2022

Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673064

25 October 2022

0 references

0 references

0 references

M. D. Lesem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673064

25 October 2022

W. H. Berrettini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673064

25 October 2022

W. H. Kaye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673064

25 October 2022

D. C. Jimerson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673064

25 October 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

full work available at URL

27 November 2017

https://api.elsevier.com/content/article/PII:000632239191286Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

https://api.elsevier.com/content/article/PII:000632239191286Z?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

25 October 2022

published in

Biological Psychiatry

1 reference

27 November 2017

volume

29

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

244-252

1 reference

Characterization of proenkephalin B-derived opioid peptides in the human hypothalamo-neurohypophyseal axis

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Naloxone decreases food intake in obese humans

25 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research.

25 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Endorphins and food intake: kappa opioid receptor agonists and hyperphagia

25 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Plasma immunoreactive beta-endorphin in bulimics

25 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

CSF β-endorphin-immunoreactivity in normal, schiziphrenic, depressed, manic and anorexic subjects

25 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Stimulation of food intake by muscimol and beta endorphin

25 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia

25 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

A rating scale for depression

25 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Treatment of antidepressant-resistant bulimia with naltrexone

25 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Cerebrospinal fluid opioid activity in anorexia nervosa

25 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa

25 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Elevated CSF dynorphin A [1-8] in Tourette's syndrome

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome

25 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Dynorphin-(1–13) induces spontaneous feeding in rats

25 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Endorphins in human cerebrospinal fluid

25 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Dynorphin A immunoreactivity in human cerebrospinal fluid

25 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Psychotomimesis mediated by kappa opiate receptors

25 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Endogenous opioid peptides and regulation of drinking and feeding

25 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Naloxone reduces the food intake of normal human volunteers

25 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Eating behavior and plasma beta-endorphin in bulimia

25 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions

25 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)91286-Z

25 October 2022

Identifiers

1 reference

27 November 2017

1 reference